文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

体重指数与糖尿病视网膜病变风险:一项荟萃分析和系统评价

Body mass index and risk of diabetic retinopathy: A meta-analysis and systematic review.

作者信息

Zhou Yue, Zhang Yuezhi, Shi Ke, Wang Changyun

机构信息

Department of Ophthalmology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.

出版信息

Medicine (Baltimore). 2017 Jun;96(22):e6754. doi: 10.1097/MD.0000000000006754.


DOI:10.1097/MD.0000000000006754
PMID:28562529
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5459694/
Abstract

Diabetic retinopathy (DR) is a frequent cause of acquired blindness worldwide. Various studies have reported the effects of body mass index (BMI) on the risk of DR, but the results remain controversial. Therefore, a meta-analysis was performed to evaluate the relationship between BMI and the risk of DR.A systematic search was performed using the Cochrane Library, PubMed, and Embase databases to obtain articles published through December 2016. Articles regarding the association between BMI and the risk of DR were retrieved. The adjusted odds ratios (ORs) and their 95% confidence intervals (CIs) were included and then pooled with a random effects model.A total of 27 articles were included in this meta-analysis. When BMI was analyzed as a categorical variable, neither being overweight (OR = 0.89, 95% CI 0.75-1.07; P = .21; I = 65%) nor obesity (OR = 0.97, 95% CI 0.73-1.30; P = .86) were associated with an increased risk of DR when compared with normal weight. When BMI was analyzed as a continuous variable, a higher BMI was not associated with an increased risk of DR (OR = 0.99, 95% CI 0.97-1.01; P = .25; I2 = 79%). The pooled results did not significantly change after the sensitivity analysis.Based on the current publications, neither being overweight nor obesity is associated with an increased risk of DR. Further studies should confirm these findings.

摘要

糖尿病性视网膜病变(DR)是全球范围内后天性失明的常见原因。各种研究报告了体重指数(BMI)对DR风险的影响,但结果仍存在争议。因此,进行了一项荟萃分析以评估BMI与DR风险之间的关系。

使用Cochrane图书馆、PubMed和Embase数据库进行系统检索,以获取截至2016年12月发表的文章。检索了关于BMI与DR风险之间关联的文章。纳入调整后的比值比(OR)及其95%置信区间(CI),然后采用随机效应模型进行汇总。

本荟萃分析共纳入27篇文章。当将BMI作为分类变量进行分析时,与正常体重相比,超重(OR = 0.89,95%CI 0.75 - 1.07;P = 0.21;I² = 65%)和肥胖(OR = 0.97,95%CI 0.73 - 1.30;P = 0.86)均与DR风险增加无关。当将BMI作为连续变量进行分析时,较高的BMI与DR风险增加无关(OR = 0.99,95%CI 0.97 - 1.01;P = 0.25;I² = 79%)。敏感性分析后汇总结果无显著变化。

基于当前的出版物,超重和肥胖均与DR风险增加无关。进一步的研究应证实这些发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5785/5459694/62b6dfa4ba13/medi-96-e6754-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5785/5459694/a4a669d971b4/medi-96-e6754-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5785/5459694/3dc198f0953e/medi-96-e6754-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5785/5459694/21802eb0023a/medi-96-e6754-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5785/5459694/62b6dfa4ba13/medi-96-e6754-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5785/5459694/a4a669d971b4/medi-96-e6754-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5785/5459694/3dc198f0953e/medi-96-e6754-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5785/5459694/21802eb0023a/medi-96-e6754-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5785/5459694/62b6dfa4ba13/medi-96-e6754-g005.jpg

相似文献

[1]
Body mass index and risk of diabetic retinopathy: A meta-analysis and systematic review.

Medicine (Baltimore). 2017-6

[2]
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Cochrane Database Syst Rev. 2017-12-22

[3]
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Health Technol Assess. 2008-6

[4]
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Cochrane Database Syst Rev. 2021-4-19

[5]
Selenium for preventing cancer.

Cochrane Database Syst Rev. 2018-1-29

[6]
Gestational weight gain below instead of within the guidelines per class of maternal obesity: a systematic review and meta-analysis of obstetrical and neonatal outcomes.

Am J Obstet Gynecol MFM. 2022-9

[7]
Prognostic factors for return to work in breast cancer survivors.

Cochrane Database Syst Rev. 2025-5-7

[8]
Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure.

Cochrane Database Syst Rev. 2007-1-24

[9]
Electronic cigarettes for smoking cessation.

Cochrane Database Syst Rev. 2022-11-17

[10]
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.

Cochrane Database Syst Rev. 2018-7-24

引用本文的文献

[1]
Exploration of the potential therapeutic benefits of naringenin against diabetic retinopathy through a National comprehensive cross-sectional study and in vitro experiments.

Diabetol Metab Syndr. 2025-8-1

[2]
Identification of Risk Factors for the Development of Diabetic Retinopathy Among Palestinian Adults With Type 2 Diabetes Mellitus: A Cross-Sectional Study.

Endocrinol Diabetes Metab. 2024-7

[3]
Impact of Bariatric Surgery on Treatment Burden and Progression of Diabetic Retinopathy.

J Vitreoretin Dis. 2024-2-13

[4]
Epidemiology of work-related injuries, musculoskeletal disorders and dermatitis among hospital food service workers in a tertiary hospital in Asia.

J Occup Med Toxicol. 2024-5-17

[5]
Novel Antidiabetic Drugs and the Risk of Diabetic Retinopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

J Clin Med. 2024-3-20

[6]
Association of Visceral Obesity Indices With Incident Diabetic Retinopathy in Patients With Diabetes: Prospective Cohort Study.

JMIR Public Health Surveill. 2024-2-6

[7]
Development and evaluation of a risk prediction model for diabetes mellitus type 2 patients with vision-threatening diabetic retinopathy.

Front Endocrinol (Lausanne). 2023

[8]
Correlation between diabetic retinopathy and infection: a cross-sectional retrospective study.

Int J Ophthalmol. 2023-8-18

[9]
Competing risks analysis for neutrophil to lymphocyte ratio as a predictor of diabetic retinopathy incidence in the Scottish population.

BMC Med. 2023-8-10

[10]
Different associations of anthropometric indices with diabetic retinopathy and diabetic kidney disease in chinese patients with type 2 diabetes mellitus.

Acta Diabetol. 2023-9

本文引用的文献

[1]
Risk factors for diabetic retinopathy: a case-control study.

Int J Retina Vitreous. 2016-9-12

[2]
Reduced serum level of leukocyte cell-derived chemotaxin 2 is associated with the presence of diabetic retinopathy.

Clin Chim Acta. 2016-12-1

[3]
Screening in Primary Care for Diabetic Retinopathy, Maculopathy and Visual Loss in South Africa.

Ophthalmologica. 2016

[4]
Risk factors for diabetic retinopathy in people with Type 2 diabetes: A case-control study in a UK primary care setting.

Prim Care Diabetes. 2016-8

[5]
Concurrent healthy behavior adoption and diabetic retinopathy in the United States.

Prev Med Rep. 2015-7-18

[6]
Differential Association of Generalized and Abdominal Obesity With Diabetic Retinopathy in Asian Patients With Type 2 Diabetes.

JAMA Ophthalmol. 2016-3

[7]
Iranian risk model as a predictive tool for retinopathy in patients with type 2 diabetes.

Can J Diabetes. 2015-3-30

[8]
Association between body mass index and diabetic retinopathy in Chinese patients with type 2 diabetes.

Acta Diabetol. 2015-8

[9]
Risk factors of diabetic retinopathy in Bangladeshi type 2 diabetic patients.

Diabetes Metab Syndr. 2011

[10]
Serum total bilirubin concentration is negatively associated with increasing severity of retinopathy in patients with type 2 diabetes mellitus.

J Diabetes Complications. 2015-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索